Results 251 to 260 of about 453,877 (390)

DETAILED ANALYSIS AND DEMONSTRATION OF DIFFERENCES IN THE KINETICS OF INDUCTION OF CLASS I AND CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS IN REJECTING CARDIAC AND KIDNEY ALLOGRAFTS IN THE RAT

Transplantation, 1986
A. Milton, S. Spencer, J. Fabre
semanticscholar   +1 more source

Massive Sampling Strategy for Antibody–Antigen Targets in CAPRI Round 55 With MassiveFold

Proteins: Structure, Function, and Bioinformatics, EarlyView.
ABSTRACT Massive sampling with AlphaFold2 improves protein–protein complex predictions. This has been shown during the last CASP15‐CAPRI blind prediction round by the AFsample tool. However, more difficult targets including antibody–antigen binding remain challenging. CAPRI Round 55 consisted of three antibody–antigen targets and one heterotrimer.
Nessim Raouraoua, Marc F. Lensink, Guillaume Brysbaert   +2 more
wiley   +1 more source

Editorial: Specific targeting of MHC antigens for T-cells and immune cells in human disease. [PDF]

Front Immunol
Afzal A, Khawar MB, Gong W, Baker BM, Sun H.   +4 more
europepmc   +1 more source

Inhibition of Major Histocompatibility Complex Class II-Dependent Antigen Presentation by Neutralization of Gamma Interferon Leads to Breakdown of Resistance against Measles Virus-Induced Encephalitis

, 2001
Gerald Weidinger, Golo Henning, Volker ter Meulen, Stefan Niewiesk   +3 more
openalex   +1 more source

A Multiple‐Model‐Informed Drug‐Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 572-582, March 2025.
ABSTRACT The antitumor efficacy of an intratumoral injection of a genetically engineered oncolytic vaccinia virus carrying human IL‐7 and murine IL‐12 genes (hIL‐7/mIL‐12‐VV) was demonstrated in CT26.WT‐bearing mice. In the CT26.WT‐bearing mouse model, the efficacy of the combination of hIL‐7/mIL‐12‐VV plus the anti‐programmed cell death protein (PD)‐1
Akihiro Yamada, Mary P. Choules, Frances A. Brightman, Shigeru Takeshita, Shinsuke Nakao, Nobuaki Amino, Takeshi Nakayama, Masato Takeuchi, Kanji Komatsu, Fernando Ortega, Hitesh Mistry, David Orrell, Christophe Chassagnole, Peter L. Bonate   +13 more
wiley   +1 more source

Vaccine-induced donor-specific HLA antibodies: a case report highlighting sensitization risks in renal transplant waitlisted patients. [PDF]

Front Immunol
Kakodkar P, Shekari N, Mainra R, Webster D, Pearce T, Wu F, Mostafa A.   +6 more
europepmc   +1 more source

Immunomodulation of Glioma Cells after Gene Therapy: Induction of Major Histocompatibility Complex Class I but Not Class II Antigen in Vitro

, 2001
Andrew T. Parsa, H. John, Patrick T. Hurley, Suriya Jeyapalan, Jeffrey N. Bruce   +4 more
openalex   +1 more source

Hetrombopag: A promising thrombopoietin receptor agonist for the treatment of primary and secondary immune thrombocytopenia

Rheumatology &Autoimmunity, EarlyView.
This review seeks to provide a thorough synthesis of the existing literature on the role of thrombopoietin receptor agonists in the treatment of primary and secondary immune thrombocytopenia, with particular emphasis on the compound Hetrombopag. Abstract Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by a platelet count below
Jiaqi Hu, Zhida Fu, Xia Xu, Zhengyi Jin, Xinyu Qian, Weiyu Tao, Taiyan Ma, Dongbao Zhao, Jie Gao   +8 more
wiley   +1 more source

Clinical settings in which human leukocyte antigen typing is still useful in the diagnosis of celiac disease. [PDF]

World J Gastroenterol
Schirru E, Rossino R, Jores RD, Corpino M, Muntoni S, Cucca F, Congia M.   +6 more
europepmc   +1 more source

CARDIAC TRANSPLANTATION IN THE RAT [PDF]

, 1989
CHAPMAN, FRANCES A, CRAMER, DONALD V, ESTES, LARRY W, HARNAHA, JO, MAKOWKA, LEONARD, QIAN, SHIQUANG, STARZL, THOMAS E   +6 more
core   +1 more source